Primer Capital
Primer Capital is a venture capital firm based in Moscow, Russia, specializing in early-stage investments in the pharmaceutical and biotechnology sectors. Established in 2015, the firm focuses on promising projects in areas such as oncology, cardiology, rheumatology, and medical devices, among others. Primer Capital typically invests between $0.2 million and $0.5 million and also considers co-investments, collaborating with various stakeholders, including other venture capital funds, business angels, and government agencies interested in the biopharmaceutical industry. The firm benefits from a qualified team and a Scientific Advisory Board made up of experts in medical and biopharmaceutical fields, which aids in the careful selection of projects for its portfolio. Primer Capital's extensive experience and knowledge of the industry ecosystem enhance the prospects for its portfolio companies, supporting them in establishing effective partnerships and facilitating fundraising throughout their development.
Top Stages
Past deals in CIS
Botkin.AI
Series B in 2020
Botkin.AI is a healthcare technology company based in Moscow, founded in 2015, specializing in medical image processing and analysis through artificial intelligence. The company's platform utilizes deep machine learning to analyze radiograms and assess the risk of tumors, enhancing the diagnostic capabilities of radiologists. By enabling the accurate early detection of oncological diseases, particularly lung cancer, Botkin.AI facilitates a faster processing of clinical data while maintaining high-quality medical conclusions. This innovative approach aims to improve the overall efficiency and effectiveness of healthcare providers in diagnosing critical conditions.
Botkin.AI
Seed Round in 2017
Botkin.AI is a healthcare technology company based in Moscow, founded in 2015, specializing in medical image processing and analysis through artificial intelligence. The company's platform utilizes deep machine learning to analyze radiograms and assess the risk of tumors, enhancing the diagnostic capabilities of radiologists. By enabling the accurate early detection of oncological diseases, particularly lung cancer, Botkin.AI facilitates a faster processing of clinical data while maintaining high-quality medical conclusions. This innovative approach aims to improve the overall efficiency and effectiveness of healthcare providers in diagnosing critical conditions.
Data MATRIX
Series A in 2016
Data MATRIX Ltd. is a data management and statistical services company based in Saint Petersburg, Russia, established in 2014. It specializes in providing cloud-based solutions for clinical data management, including its proprietary Matrix EDC platform, which facilitates electronic, paper-based, and hybrid studies. The company also offers Matrix IWRS for patient randomization and supply management, as well as Matrix CTMS for overseeing clinical trials. Data MATRIX supports the entire clinical research process by providing services such as data work planning, case report form design, and database customization. It employs both automated and manual methods for data verification while ensuring compliance with international and local regulations regarding personal data processing. Additionally, the company offers ePRO solutions aimed at improving the quality of patient-reported outcomes. With a focus on innovation, Data MATRIX integrates artificial intelligence tools to enhance data management, enabling biotechnology firms to streamline their clinical trial operations and reporting functions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.